Pharmacovigilance and reporting oversight in us fda fast-track process: Bisphosphonates and osteonecrosis of the jaw
10.1016/S1470-2045(08)70305-X 19038763
BJ Edwards M Gounder JM McKoy I Boyd M Farrugia C Migliorati R Marx S Ruggiero M Dimopoulos DW Raisch S Singhal K Carson E Obadina S Trifilio D West CL Mehta JBennett 2008 Pharmacovigilance and reporting oversight in us fda fast-track process: bisphosphonates and osteonecrosis of the jaw Lancet Oncol 9 1166 1172 10.1016/S1470-2045(08)70305-X 19038763
Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: A possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings
10.1007/s00784-00009-00300-00786
S Hoefert I Schmitz H Tannapfel AEufinger 2009 Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings Clin Oral Investig 10.1007/s00784-00009-00300-00786
More on atypical fractures of the femoral diaphysis
10.1056/NEJMc080861 18635442 author reply 317-318
EB Kwek TS Koh JSHowe 2008 More on atypical fractures of the femoral diaphysis N Engl J Med 359 316 317 10.1056/NEJMc080861 18635442 author reply 317-318
Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate
10.1056/NEJMc0707493 18354114
BA Lenart JM Lorich DGLane 2008 Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate N Engl J Med 358 1304 1306 10.1056/NEJMc0707493 18354114
Association of low-energy femoral fractures with prolonged bisphosphonate use: A case control study
10.1007/s00198-00008-00805-x 19066707
BA Lenart AS Neviaser S Lyman CC Chang F Edobor-Osula B Steele MC van der Meulen JM Lorich DGLane 2008 Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study Osteoporos Int 10.1007/s00198-00008-00805-x 19066707
Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients
doi:
Kyrgidis A, Triaridis S, Vahtsevanos K, Antoniades K. (2009) Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients. Expert Review of Anticancer Therapy 9(8). doi: 10.1586/ERA.09.74
Effects of bisphosphonates on keratinocytes and fibroblasts may have a role in the development of osteonecrosis of the jaw
10.1016/j.bihy.2009.02.005
A Kyrgidis S Triaridis K Antoniades 2009 Effects of bisphosphonates on keratinocytes and fibroblasts may have a role in the development of osteonecrosis of the jaw Bioscience Hypotheses 2 153 159 10.1016/j.bihy.2009.02. 005